480 related articles for article (PubMed ID: 25757056)
1. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.
Dragon J; Thompson J; MacPherson M; Shukla A
J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.
Borczuk AC; Pei J; Taub RN; Levy B; Nahum O; Chen J; Chen K; Testa JR
Cancer Biol Ther; 2016; 17(3):328-35. PubMed ID: 26853494
[TBL] [Abstract][Full Text] [Related]
3. Malignant Mesothelioma and Its Non-Asbestos Causes.
Attanoos RL; Churg A; Galateau-Salle F; Gibbs AR; Roggli VL
Arch Pathol Lab Med; 2018 Jun; 142(6):753-760. PubMed ID: 29480760
[TBL] [Abstract][Full Text] [Related]
4. Global overexpression of divalent metal transporter 1 delays crocidolite-induced mesothelial carcinogenesis in male mice.
Funahashi S; Okazaki Y; Nishiyama T; Ohyoshi H; Yasui H; Nishida K; Matsui S; Toyokuni S
Free Radic Res; 2018 Sep; 52(9):1030-1039. PubMed ID: 30309285
[TBL] [Abstract][Full Text] [Related]
5. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
[TBL] [Abstract][Full Text] [Related]
6. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
[TBL] [Abstract][Full Text] [Related]
7. Asbestos fibers contributing to the induction of human malignant mesothelioma.
Suzuki Y; Yuen SR
Ann N Y Acad Sci; 2002 Dec; 982():160-76. PubMed ID: 12562635
[TBL] [Abstract][Full Text] [Related]
8. Biological agents involved in malignant mesothelioma: relevance as biomarkers or therapeutic targets.
Crispi S; Cardillo I; Spugnini EP; Citro G; Menegozzo S; Baldi A
Curr Cancer Drug Targets; 2010 Feb; 10(1):19-26. PubMed ID: 20088796
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
[TBL] [Abstract][Full Text] [Related]
10. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
Tunesi S; Ferrante D; Mirabelli D; Andorno S; Betti M; Fiorito G; Guarrera S; Casalone E; Neri M; Ugolini D; Bonassi S; Matullo G; Dianzani I; Magnani C
Carcinogenesis; 2015 Oct; 36(10):1129-35. PubMed ID: 26139392
[TBL] [Abstract][Full Text] [Related]
11. Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice.
Vaslet CA; Messier NJ; Kane AB
Toxicol Sci; 2002 Aug; 68(2):331-8. PubMed ID: 12151629
[TBL] [Abstract][Full Text] [Related]
12. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC
Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287
[TBL] [Abstract][Full Text] [Related]
13. An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injury.
Shukla A; Barrett TF; MacPherson MB; Hillegass JM; Fukagawa NK; Swain WA; O'Byrne KJ; Testa JR; Pass HI; Faux SP; Mossman BT
Am J Respir Cell Mol Biol; 2011 Nov; 45(5):906-14. PubMed ID: 21454801
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
[TBL] [Abstract][Full Text] [Related]
15. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations.
Shivapurkar N; Wiethege T; Wistuba II; Salomon E; Milchgrub S; Muller KM; Churg A; Pass H; Gazdar AF
J Cell Biochem; 1999 Dec; 76(2):181-8. PubMed ID: 10618635
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of mesothelioma in vinylidene chloride-exposed F344/N rats reveal immune dysfunction, tissue damage, and inflammation pathways.
Blackshear PE; Pandiri AR; Nagai H; Bhusari S; Hong HH; Ton TV; Clayton NP; Wyde M; Shockley KR; Peddada SD; Gerrish KE; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Feb; 43(2):171-85. PubMed ID: 24958746
[TBL] [Abstract][Full Text] [Related]
17. Cancer-promoting role of adipocytes in asbestos-induced mesothelial carcinogenesis through dysregulated adipocytokine production.
Chew SH; Okazaki Y; Nagai H; Misawa N; Akatsuka S; Yamashita K; Jiang L; Yamashita Y; Noguchi M; Hosoda K; Sekido Y; Takahashi T; Toyokuni S
Carcinogenesis; 2014 Jan; 35(1):164-72. PubMed ID: 23917077
[TBL] [Abstract][Full Text] [Related]
18. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
Ramírez-Salazar EG; Salinas-Silva LC; Vázquez-Manríquez ME; Gayosso-Gómez LV; Negrete-Garcia MC; Ramírez-Rodriguez SL; Chávez R; Zenteno E; Santillán P; Kelly-García J; Ortiz-Quintero B
Exp Mol Pathol; 2014 Dec; 97(3):375-85. PubMed ID: 25236577
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Cytokines Contribute to Asbestos-Induced Injury of Mesothelial Cells.
Acencio MM; Soares B; Marchi E; Silva CS; Teixeira LR; Broaddus VC
Lung; 2015 Oct; 193(5):831-7. PubMed ID: 26059286
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G
J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
